Company record · AMGN · Biological Products, (No Diagnostic Substances)
Amgen
The principal financial officer who signed Amgen's latest annual report is Peter H. Griffith, verified February 13, 2026.
Roster record
| Officer | Peter H. Griffith |
|---|---|
| Verified | February 13, 2026 (filing date of the source) |
| Note | The DEF 14A filed 2026-04-07 also names Peter H. Griffith alongside a Chief Financial Officer title. An 8-K with Item 5.02 was filed on 2026-05-19, after this 10-K; any CFO change it reports is tracked on the moves record. |
- sec.gov · signature block · “/s/ PETER H. GRIFFITH Peter H. Griffith Executive Vice President and Chief Financial Officer (Principal Financial Officer)”
This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.